Published in Clin Microbiol Rev on October 01, 1997
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A (2001) 3.42
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A (2002) 3.18
Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev (2001) 2.97
Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr (2009) 2.71
pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infect Immun (2003) 2.41
Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol (2000) 2.25
Helicobacter pylori physiology predicted from genomic comparison of two strains. Microbiol Mol Biol Rev (1999) 2.13
The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun (1998) 2.05
Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia. Saudi J Gastroenterol (2014) 1.97
Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol (2010) 1.96
Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene. J Bacteriol (2000) 1.83
Manipulation of rab GTPase function by intracellular bacterial pathogens. Microbiol Mol Biol Rev (2007) 1.82
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A (2004) 1.77
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol (2000) 1.73
The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J Bacteriol (1999) 1.69
Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev (2009) 1.68
Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J Bacteriol (2000) 1.66
The Helicobacter pylori homologue of the ferric uptake regulator is involved in acid resistance. Infect Immun (2002) 1.65
Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol (2004) 1.63
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun (2003) 1.60
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother (2001) 1.60
Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun (2001) 1.59
Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother (2000) 1.58
The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol (2008) 1.57
Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens. Clin Diagn Lab Immunol (2002) 1.55
The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol (2006) 1.55
Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol (1998) 1.52
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Iron and pH homeostasis intersect at the level of Fur regulation in the gastric pathogen Helicobacter pylori. Infect Immun (2006) 1.48
A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol (2001) 1.47
The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. Mol Biol Cell (2005) 1.46
Oxidative-stress resistance mutants of Helicobacter pylori. J Bacteriol (2002) 1.45
Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect Immun (2004) 1.45
An NADPH quinone reductase of Helicobacter pylori plays an important role in oxidative stress resistance and host colonization. Infect Immun (2004) 1.45
Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun (2002) 1.43
Oral Cavity as an Extragastric Reservoir of Helicobacter pylori. ISRN Gastroenterol (2014) 1.43
Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides. PLoS One (2015) 1.39
Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis. J Clin Microbiol (1999) 1.38
NikR mediates nickel-responsive transcriptional induction of urease expression in Helicobacter pylori. Infect Immun (2002) 1.37
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol (2001) 1.37
Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. Infect Immun (2001) 1.33
Frequent association between alteration of the rdxA gene and metronidazole resistance in French and North African isolates of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.31
Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother (2005) 1.31
Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother (1999) 1.30
Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer (2007) 1.30
Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins. Biochem J (2004) 1.28
Isolation and identification of Helicobacter spp. from canine and feline gastric mucosa. Appl Environ Microbiol (1998) 1.26
Two different families of hopQ alleles in Helicobacter pylori. J Clin Microbiol (2002) 1.25
Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet (2003) 1.25
Mutational analysis of the vacA promoter provides insight into gene transcription in Helicobacter pylori. J Bacteriol (1999) 1.24
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut (2000) 1.24
Transcriptional phase variation of a type III restriction-modification system in Helicobacter pylori. J Bacteriol (2002) 1.23
Identification of virulence genes of Helicobacter pylori by random insertion mutagenesis. Infect Immun (1999) 1.23
Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR. J Clin Microbiol (2003) 1.23
Acid-responsive gene induction of ammonia-producing enzymes in Helicobacter pylori is mediated via a metal-responsive repressor cascade. Infect Immun (2004) 1.22
In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol (2004) 1.22
16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother (2002) 1.21
Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host lewis phenotype and inflammatory response. Infect Immun (2000) 1.21
Determination of the infectious dose of Helicobacter pylori during primary and secondary infection in rhesus monkeys (Macaca mulatta). Infect Immun (2001) 1.21
Contribution of the Helicobacter pylori thiol peroxidase bacterioferritin comigratory protein to oxidative stress resistance and host colonization. Infect Immun (2005) 1.20
Pathogen evolution in vivo: genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain. J Clin Microbiol (2005) 1.20
The Helicobacter pylori CrdRS two-component regulation system (HP1364/HP1365) is required for copper-mediated induction of the copper resistance determinant CrdA. J Bacteriol (2005) 1.20
In vivo distribution of Helicobacter felis in the gastric mucus of the mouse: experimental method and results. Infect Immun (1999) 1.20
Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect Immun (2001) 1.19
The neutrophil-activating Dps protein of Helicobacter pylori, HP-NAP, adopts a mechanism different from Escherichia coli Dps to bind and condense DNA. Nucleic Acids Res (2007) 1.18
Expanding the Helicobacter pylori genetic toolbox: modification of an endogenous plasmid for use as a transcriptional reporter and complementation vector. Appl Environ Microbiol (2007) 1.18
Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect Immun (2004) 1.17
Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (2003) 1.16
Persistence of Helicobacter pylori in heterotrophic drinking-water biofilms. Appl Environ Microbiol (2008) 1.15
Presence of active aliphatic amidases in Helicobacter species able to colonize the stomach. Infect Immun (2003) 1.15
Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect Immun (2005) 1.15
Development of an interleukin-12-deficient mouse model that is permissive for colonization by a motile KE26695 strain of Helicobacter pylori. Infect Immun (2003) 1.15
Helicobacter pylori endemic and gastric disease. Dig Dis Sci (2005) 1.15
Identification of non-Helicobacter pylori spiral organisms in gastric samples from humans, dogs, and cats. J Clin Microbiol (2005) 1.15
Global analysis of Helicobacter pylori gene expression in human gastric mucosa. Gastroenterology (2002) 1.14
A cultured strain of "Helicobacter heilmannii," a human gastric pathogen, identified as H. bizzozeronii: evidence for zoonotic potential of Helicobacter. Emerg Infect Dis (2001) 1.14
Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrob Agents Chemother (1999) 1.14
Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol (2008) 1.14
Oxidative stress-induced peptidoglycan deacetylase in Helicobacter pylori. J Biol Chem (2009) 1.13
Epidemiological link between gastric disease and polymorphisms in VacA and CagA. J Clin Microbiol (2009) 1.13
Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.12
Superoxide dismutases and superoxide reductases. Chem Rev (2014) 1.12
Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol (2004) 1.12
Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect Immun (2006) 1.11
Helicobacter pylori mutants defective in RuvC Holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infect Immun (2003) 1.11
Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. Int J Mol Sci (2012) 1.11
Virulence of water-induced coccoid Helicobacter pylori and its experimental infection in mice. World J Gastroenterol (2003) 1.10
Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. J Clin Microbiol (2007) 1.10
A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother (2005) 1.10
Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob Agents Chemother (1999) 1.10
Magnesium uptake by CorA is essential for viability of the gastric pathogen Helicobacter pylori. Infect Immun (2002) 1.10
Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response. J Clin Microbiol (2001) 1.09
The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect Immun (2006) 1.09
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol (2000) 1.09
A conventional beagle dog model for acute and chronic infection with Helicobacter pylori. Infect Immun (1999) 1.09
Cloning, expression, and catalytic activity of Helicobacter hepaticus urease. Infect Immun (2001) 1.09
Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques. J Clin Microbiol (2003) 1.08
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet (1984) 32.58
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res (1992) 12.77
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet (1993) 11.38
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Helicobacter pylori infection and gastric lymphoma. N Engl J Med (1994) 10.26
Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol (1984) 10.23
Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ (1991) 9.88
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet (1991) 9.51
Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol (1988) 8.69
Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science (1993) 7.86
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet (1984) 7.45
Isolation of Helicobacter pylori from human faeces. Lancet (1992) 7.32
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis (1990) 6.90
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32
Molecular biology of microbial ureases. Microbiol Rev (1995) 6.31
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ (1995) 6.28
Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med (1994) 6.24
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun (1991) 5.90
Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73
Helicobacter pylori and peptic ulcer disease. N Engl J Med (1991) 5.43
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med (1995) 5.15
Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet (1995) 5.14
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology (1991) 4.86
Spiral bacteria of the gastric antrum. Lancet (1984) 4.74
Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology (1992) 4.63
Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet (1997) 4.63
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The cohort effect and Helicobacter pylori. J Infect Dis (1993) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol (1985) 4.05
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol (1995) 3.86
Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun (1989) 3.81
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates. J Clin Microbiol (1992) 3.56
Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol (1994) 3.47
Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet (1994) 3.45
Indicator medium for isolation of Campylobacter pylori. J Clin Microbiol (1987) 3.44
Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect Immun (1994) 3.42
Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest (1994) 3.40
Purification and N-terminal analysis of urease from Helicobacter pylori. Infect Immun (1990) 3.40
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun (1996) 3.36
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20
Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J Bacteriol (1992) 3.16
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J (1994) 3.13
Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09
Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun (1990) 3.01
Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ (1996) 3.00
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96
A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. Infect Immun (1994) 2.94
Ordered cosmid library and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638. Mol Microbiol (1994) 2.93
Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J Med Microbiol (1992) 2.92
Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun (1994) 2.89
Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun (1996) 2.80
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun (1996) 2.75
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect (1993) 2.61
Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut (1996) 2.58
Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res (1996) 2.56
An uncultured gastric spiral organism is a newly identified Helicobacter in humans. J Infect Dis (1993) 2.53
An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc Natl Acad Sci U S A (1993) 2.44
Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett (1996) 2.42
Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine (1993) 2.36
Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36
Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Mol Microbiol (1996) 2.35
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther (1995) 2.27
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26
Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun (1995) 2.23
Metronidazole resistance in Helicobacter pylori. Lancet (1990) 2.21
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 2.20
Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci U S A (1994) 2.19
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Campylobacter enteritis. N Engl J Med (1981) 7.98
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology (1987) 7.27
Epidemiology of Campylobacter jejuni infections. Epidemiol Rev (1983) 7.06
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem (1992) 6.54
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Survival of Campylobacter fetus subsp. jejuni in biological milieus. J Clin Microbiol (1980) 6.04
Campylobacter pylori antibodies in humans. Ann Intern Med (1988) 6.02
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med (1990) 5.09
The clinical significance of Campylobacter pylori. Ann Intern Med (1988) 5.08
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet (1998) 5.02
Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology (1995) 4.42
The epidemiology of Helicobacter pylori infection. Epidemiol Rev (1991) 4.40
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis (1988) 4.28
Purification and characterization of urease from Helicobacter pylori. J Biol Chem (1990) 4.22
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol (1995) 3.97
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun (1991) 3.57
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
Renal function during antihypertensive treatment. Lancet (1995) 3.33
Identification and characterization of Campylobacter jejuni outer membrane proteins. Infect Immun (1983) 3.24
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med (1994) 3.19
Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol (1980) 3.11
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med (1992) 3.03
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A (1998) 2.96
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Isolation of Campylobacter fetus subsp. jejuni from Bangladeshi children. J Clin Microbiol (1980) 2.92
A review of human salmonellosis: I. Infective dose. Rev Infect Dis (1983) 2.91
Reservoirs for human campylobacteriosis. J Infect Dis (1980) 2.87
Detection of Listeria monocytogenes by using the polymerase chain reaction. Appl Environ Microbiol (1990) 2.84
Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun (1987) 2.82
Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians (1999) 2.77
Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med (2001) 2.76
Helicobacter pylori and gastroduodenal disease. Annu Rev Med (1992) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) (2012) 2.72
Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis (1985) 2.71
Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis (1990) 2.71
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest (2001) 2.70
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol (1998) 2.65
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ (1993) 2.49
Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension (1999) 2.44
Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart from the same host. J Infect Dis (2000) 2.42
Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect Immun (1984) 2.41
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension (1994) 2.35
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ (1999) 2.31
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Guidelines for the clinical use of red cell transfusions. Br J Haematol (2001) 2.21
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol (1996) 2.21
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
Campylobacter enteritis associated with unpasteurized milk. Am J Med (1979) 2.19
Campylobacter enteritis from untreated water in the Rocky Mountains. Ann Intern Med (1983) 2.17
An outbreak of waterborne giardiasis associated with heavy water runoff due to warm weather and volcanic ashfall. Am J Public Health (1983) 2.16
Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG (2013) 2.16
Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis (1993) 2.15
MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Cellular fatty acid composition of Campylobacter fetus. J Clin Microbiol (1980) 2.14
Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol (2000) 2.14
Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun (1998) 2.14
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
Pathophysiology of Campylobacter jejuni infections of humans. Microbes Infect (1999) 2.10
Comment of N.O.P.H.N. Field Staff on Seattle and Richmond Reports. Am J Public Health Nations Health (1948) 2.06
Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens. J Clin Microbiol (1981) 2.06
A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis (1984) 2.04
From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis (1981) 2.04